Cancel cancer: Russia unveils next-gen vaccine revolution

On the latest episode, Rick sits down with the former Russian health minister and director of the Russian Federal medical-biological agency Veronika Skvortsova. She first pulls back the curtain on a cutting-edge dengue vaccine set to shield millions of Latin American communities. She shares that the formula has sailed through safety trials, and rapid-track field testing will begin once the data confirms its promise.

The conversation swings to a second marvel – a personalized cancer vaccine that zeroes in on a patient’s own mutated tumor proteins. Thanks to its AI-driven design, Skvortsova explains that the vaccine can be customized in a fraction of the time it would take a human based trial, a leap that could shorten the road to its efficiency.

Join Rick and Veronika for a glimpse of how Russia is turning cancer from an inevitable fate into a manageable condition. Watch the latest episode, only on RT.